130 related articles for article (PubMed ID: 37506532)
1. Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus.
Feizi S; Awad M; Nepal R; Cooksley CM; Psaltis AJ; Wormald PJ; Vreugde S
Tuberculosis (Edinb); 2023 Sep; 142():102390. PubMed ID: 37506532
[TBL] [Abstract][Full Text] [Related]
2. Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in
Richter K; Thomas N; Zhang G; Prestidge CA; Coenye T; Wormald PJ; Vreugde S
Front Cell Infect Microbiol; 2017; 7():280. PubMed ID: 28690982
[TBL] [Abstract][Full Text] [Related]
3. Mind "De GaPP": in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms.
Richter K; Ramezanpour M; Thomas N; Prestidge CA; Wormald PJ; Vreugde S
Int Forum Allergy Rhinol; 2016 Jul; 6(7):737-43. PubMed ID: 26919404
[TBL] [Abstract][Full Text] [Related]
4. Gallium Porphyrin and Gallium Nitrate Synergistically Inhibit
Choi SR; Switzer B; Britigan BE; Narayanasamy P
ACS Infect Dis; 2020 Oct; 6(10):2582-2591. PubMed ID: 32845117
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
6. A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity.
Richter K; Thomas N; Claeys J; McGuane J; Prestidge CA; Coenye T; Wormald PJ; Vreugde S
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396543
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone-Gallium-Protoporphyrin Chitogel Decreases
Kennewell TL; Haidari H; Mashtoub S; Howarth GS; Bennett C; Cooksley CM; Wormald PJ; Cowin AJ; Vreugde S; Kopecki Z
Materials (Basel); 2024 Feb; 17(4):. PubMed ID: 38399044
[No Abstract] [Full Text] [Related]
8. Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.
Abdalla MY; Switzer BL; Goss CH; Aitken ML; Singh PK; Britigan BE
Antimicrob Agents Chemother; 2015 Aug; 59(8):4826-34. PubMed ID: 26033732
[TBL] [Abstract][Full Text] [Related]
9. Combination Therapy with Gallium Protoporphyrin and Gallium Nitrate Exhibits Enhanced Antimicrobial Activity
Choi SR; Talmon GA; Hearne K; Woo J; Truong VL; Britigan BE; Narayanasamy P
Mol Pharm; 2023 Aug; 20(8):4058-4070. PubMed ID: 37471668
[TBL] [Abstract][Full Text] [Related]
10. Gallium protoporphyrin as an antimicrobial for non-typeable Haemophilus influenzae in COPD patients.
Baker JM; Baba-Dikwa A; Shah R; Lea S; Singh D
Life Sci; 2022 Sep; 305():120794. PubMed ID: 35835251
[TBL] [Abstract][Full Text] [Related]
11. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
[TBL] [Abstract][Full Text] [Related]
12. Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against
Lee DG; Hwang YH; Park EJ; Kim JH; Ryoo SW
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681686
[No Abstract] [Full Text] [Related]
13. Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in
Ruth MM; van Rossum M; Koeken VACM; Pennings LJ; Svensson EM; Ruesen C; Bowles EC; Wertheim HFL; Hoefsloot W; van Ingen J
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262763
[TBL] [Abstract][Full Text] [Related]
14. Liquid crystalline lipid nanoparticle promotes the photodynamic activity of gallium protoporphyrin against S. aureus biofilms.
Awad M; Barnes TJ; Joyce P; Thomas N; Prestidge CA
J Photochem Photobiol B; 2022 Jul; 232():112474. PubMed ID: 35644068
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial properties of basidiomycota macrofungi to
Millar BC; Nelson D; Moore RE; Rao JR; Moore JE
Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186
[TBL] [Abstract][Full Text] [Related]
16. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis.
Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL
Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329
[TBL] [Abstract][Full Text] [Related]
17. Activity of Oritavancin and Its Synergy with Other Antibiotics against
Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
[TBL] [Abstract][Full Text] [Related]
18. Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report.
Addy C; Doran G; Jones AL; Wright G; Caskey S; Downey DG
BMC Pulm Med; 2018 Nov; 18(1):170. PubMed ID: 30453935
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model.
Molina-Torres CA; Tamez-Peña L; Castro-Garza J; Ocampo-Candiani J; Vera-Cabrera L
J Microbiol Methods; 2018 May; 148():29-32. PubMed ID: 29626567
[TBL] [Abstract][Full Text] [Related]
20. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
Moore RE; Millar BC; Panickar JR; Moore JE
Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
